Mallinckrodt’s INOmax Granted Approved In Japan and Australia For Pulmonary Hypertension In Conjunction With Heart Surgery
News, Pulmonary Hypertension
Biopharmaceutical company Mallinckrodt plc., recently announced that INOmax® (nitric oxide) for inhalation has been approved in Japan for pulmonary hypertension associated with heart surgery. INOmax is a vasodilator that improves ventilation/perfusion (V/Q) ... Read more